Your browser doesn't support javascript.
loading
Surgical Management of Primary Pulmonary Artery Sarcoma.
Chan, Edward Y; Ravi, Vinod; Ali, Areeba; Nguyen, Duc T; Graviss, Edward A; MacGillivray, Thomas E; Reardon, Michael J.
Afiliação
  • Chan EY; Department of Surgery, Houston Methodist Hospital, Houston, Texas.
  • Ravi V; Department of Sarcoma Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Ali A; Houston Methodist Research Institute, Houston, Texas.
  • Nguyen DT; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute.
  • Graviss EA; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas.
  • MacGillivray TE; Department of Cardiovascular Surgery, Houston Methodist Hospital, Houston, Texas.
  • Reardon MJ; Department of Cardiovascular Surgery, Houston Methodist Hospital, Houston, Texas. Electronic address: mreardon@houstonmethodist.org.
Semin Thorac Cardiovasc Surg ; 35(1): 53-64, 2023.
Article em En | MEDLINE | ID: mdl-34743005
Primary pulmonary artery sarcoma is a rare cardiac tumor with a dismal prognosis without surgical therapy. It is often confused with the more common chronic pulmonary emboli which may delay the appropriate diagnosis or lead to suboptimal surgery. The objective of this study was to evaluate the short and long-term survival and local recurrence rate of pulmonary artery sarcoma cases operated on at our institution using an anatomic resection approach for the pulmonary trunk and main pulmonary arteries rather than endarterectomy. We searched our prospectively collected cardiac tumor database for cases of primary pulmonary sarcoma operated at our institution between June 2000 and September 2018 and followed until January 3, 2021. We used an anatomic resection and replacement technique for involved pulmonary root and main pulmonary arteries with endarterectomy used only for disease distal to the first arterial branch when lung preservation was possible. The primary endpoints for our study were survival from the time of initial diagnosis and survival from the time of our surgery. Secondary endpoints were operative 30-day mortality and incidence of local recurrence or metastatic disease. We identified 20 consecutive cases of surgical resection of primary pulmonary sarcoma. The median age at surgery was 52.5 years (IQR 43.5-60.5). Complete pulmonary root resection and reconstruction using a pulmonary homograft were needed in 16/20 (80%) of cases. All resections employed cardiopulmonary bypass with cardioplegic arrest. A pneumonectomy was needed in 7/20 (35%) of patients. A negative margin (R0) resection was achieved in 9 patients (45%) and margins were microscopically positive (R1) on final pathology in 9 patients (45%). Two patients (10%) had gross tumor (R2) at the resection margin. Operative mortality was 2/20 (10%). Median survival was 2.8 years from diagnosis (95% CI 1.3-8.8) and 2.7 years from surgery by our team (95% CI 0.8-5.9). Survival from first initial diagnosis at 1, 3, 5, and 10 years was 85.0%, 49.1%, 49.1%, and 16.4%. Survival from our surgery by our team at 1, 3, 5, and 10 years was 70%, 48.8%, 41.8%, and 8.4%. Surgical resection of primary pulmonary artery sarcoma with an approach utilizing an anatomic resection of the pulmonary root and main pulmonary arteries when involved and pneumonectomy or endarterectomy when there is disease distal to the first branch artery can be done with a reasonable operative risk and long-term survival when compared to the natural history of the disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Cardíacas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Cardíacas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article